Publications by authors named "Jan P Mattsson"

Claim this Profile
E
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial.
Nadia Ovchinsky, Madeleine Aumar, Alastair Baker, Ulrich Baumann, Philip Bufler, Jan P Mattsson

Lancet Gastroenterol Hepatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans.
Francisco J Caballero-Camino, Pedro M Rodrigues, Fredrik Wångsell, Aloña Agirre-Lizaso, Paula Olaizola, Jan P Mattsson

Hepatology· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis.
Richard J Thompson, Reha Artan, Ulrich Baumann, Pier Luigi Calvo, Piotr Czubkowski, Jan P Mattsson

JHEP Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.
Richard J Thompson, Henrik Arnell, Reha Artan, Ulrich Baumann, Pier Luigi Calvo, Jan P Mattsson

Lancet Gastroenterol Hepatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation.
Atsushi Nakajima, Sonoko Ishizaki, Kazuki Matsuda, Shinsuke Kurosu, Shinya Taniguchi, Jan P Mattsson

J Gastroenterol Hepatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.
Ulrich Baumann, Ekkehard Sturm, Florence Lacaille, Emmanuel Gonzalès, Henrik Arnell, Jan P Mattsson

Clin Res Hepatol Gastroenterol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review and Meta-analysis: Partial External Biliary Diversion in Progressive Familial Intrahepatic Cholestasis.
Henkjan J Verkade, Richard J Thompson, Henrik Arnell, Björn Fischler, Per-Göran Gillberg, Jan P Mattsson

J Pediatr Gastroenterol Nutr· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, long-term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in Japan.
Atsushi Nakajima, Shinya Taniguchi, Shinsuke Kurosu, Per-Göran Gillberg, Jan P Mattsson

Neurogastroenterol Motil· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.
Atsushi Nakajima, Mitsunori Seki, Shinya Taniguchi, Akira Ohta, Per-Göran Gillberg, Jan P Mattsson

Lancet Gastroenterol Hepatol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic expression of the TRPM subgroup of ion channels in developing mouse sensory neurons.
Susanne Staaf, Marina C M Franck, Frédéric Marmigère, Jan P Mattsson, Patrik Ernfors

Gene Expr Patterns· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(R)-(3-amino-2-fluoropropyl) phosphinic acid (AZD3355), a novel GABAB receptor agonist, inhibits transient lower esophageal sphincter relaxation through a peripheral mode of action.
Anders Lehmann, Madeleine Antonsson, Ann Aurell Holmberg, L Ashley Blackshaw, Lena Brändén, Jan P Mattsson

J Pharmacol Exp Ther· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential regulation of TRP channels in a rat model of neuropathic pain.
Susanne Staaf, Sandra Oerther, Guilherme Lucas, Jan P Mattsson, Patrik Ernfors

Pain· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down regulation of TRPC1 by shRNA reduces mechanosensitivity in mouse dorsal root ganglion neurons in vitro.
Susanne Staaf, Ingela Maxvall, Ulrika Lind, Johanna Husmark, Jan P Mattsson

Neurosci Lett· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and pharmacological evaluation of novel gamma-aminobutyric acid type B (GABAB) receptor agonists as gastroesophageal reflux inhibitors.
Christer Alstermark, Kosrat Amin, Sean R Dinn, Thomas Elebring, Ola Fjellström, Jan P Mattsson

J Med Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular subtype distribution and developmental regulation of TRPC channel members in the mouse dorsal root ganglion.
Susanne Elg, Frederic Marmigere, Jan P Mattsson, Patrik Ernfors

J Comp Neurol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship of thiopyrimidines as mGluR5 antagonists.
Lance G Hammerland, Martin Johansson, Jonas Malmström, Jan P Mattsson, Alexander B E Minidis

Bioorg Med Chem Lett· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenyl ureas of creatinine as mGluR5 antagonists. A structure-activity relationship study of fenobam analogues.
Andreas Wållberg, Karolina Nilsson, Krister Osterlund, Alecia Peterson, Susanne Elg, Jan P Mattsson

Bioorg Med Chem Lett· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of (2R)-(3-amino-2-fluoropropyl)sulphinic acid (AFPSiA) on transient lower oesophageal sphincter relaxation in dogs and mechanism of hypothermic effects in mice.
Anders Lehmann, Ann Aurell Holmberg, Ulhas Bhatt, Marianne Bremner-Danielsen, Lena Brändén, Jan P Mattsson

Br J Pharmacol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient lower esophageal sphincter relaxations in dogs are inhibited by a metabotropic glutamate receptor 5 antagonist.
Jörgen Jensen, Anders Lehmann, Anna Uvebrant, Anita Carlsson, Gunilla Jerndal, Jan P Mattsson

Eur J Pharmacol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of transient lower esophageal sphincter relaxation and gastroesophageal reflux by metabotropic glutamate receptor ligands.
Claudine L Frisby, Jan P Mattsson, Jörgen M Jensen, Anders Lehmann, John Dent

Gastroenterology· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabotropic glutamate receptors inhibit mechanosensitivity in vagal sensory neurons.
Amanda J Page, Richard L Young, Chris M Martin, Mia Umaerus, Tracey A O'Donnell, Jan P Mattsson

Gastroenterology· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of GABA agonists on body temperature regulation in GABA(B(1))-/- mice.
Christophe Quéva, Marianne Bremner-Danielsen, Anders Edlund, A Jonas Ekstrand, Susanne Elg, Jan P Mattsson

Br J Pharmacol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of repeated administration of baclofen to rats on GABAB receptor binding sites and subunit expression in the brain.
Anders Lehmann, Jan P Mattsson, Anders Edlund, Thore Johansson, A Jonas Ekstrand

Neurochem Res· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anticonvulsant gabapentin (neurontin) does not act through gamma-aminobutyric acid-B receptors.
Anders A Jensen, Johannes Mosbacher, Susanne Elg, Kurt Lingenhoehl, Tania Lohmann, Jan P Mattsson

Mol Pharmacol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis